Bora Pharmaceuticals is a leading contract development and manufacturing organization (CDMO) that specializes in complex modified release manufacturing and solvent processing for non-sterile oral solid dosage forms.
Currently employing over 475 people across its two state-of-the-art facilities in Taiwan and supplying to over 17 countries across the world, including the USA and the UK., the publicly listed (6472.TWO) CDMO has the agility and expertise to take on challenging, large-scale projects, offering tailored solutions for niche drug product requirements at a global scale.